STE 62.66 Steris Corp $STE Hit a 52 week high of 64.90

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
STE 62.66 Steris Corp $STE Hit a 52 week high of 64.90 Closing the day 11/05/14 at 62.66 +0.22 +0.35% With a day low of 62.54 and a total volume of 944,942.

STE Recent Posts: http://investorshangout.com/Steris-Corp-STE-52725/

STE Steris Corp Recent Headline News

Steris
at Investor's Business Daily - Wed Nov 05, 5:48PM CST
Steris (STE) earnings rose 23.6% to 68 cents, topping by a nickel. Revenue increased 20.6% to $462.7 mil, above views for $452.5 mil. The company set full-year EPS outlook for $2.86-$2.91 vs. views for $2.88 a share. Shares rose 0.4% to 62.66.
STE: 62.66 (+0.22)

Stocks Turn Mixed; Epam Bounces Back
at Investor's Business Daily - Tue Nov 04, 2:13PM CST
Stocks continued to improve late Tuesday, turning mixed. The Dow Jones industrial average bounced back from a 0.5% loss and was up a fraction. The broader Nasdaq and the S&P 500 were off 0.4% each. They had been off 0.9% and 0.8%, respectively. NYSE...
FEYE: 29.12 (-5.13), AWAY: 28.58 (-5.17), FRGI: 58.00 (+2.58), SAVE: 75.41 (-1.21), LNKD: 218.18 (-20.25), SCTY: 54.44 (-2.52), STE: 62.66 (+0.22), PZZA: 49.52 (+2.82), JAZZ: 167.18 (-1.30), FL: 52.71 (-0.92), EPAM: 48.25 (+1.64)

Steris tops Street 2Q forecasts
Automated Insights - Tue Nov 04, 11:48AM CST
MENTOR, Ohio (AP) _ Steris Corp. (STE) on Tuesday reported earnings of $31 million in its fiscal second quarter.
STE: 62.66 (+0.22)

STERIS Corporation Announces Fiscal 2015 Second Quarter Results
Thomson Reuters ONE - Tue Nov 04, 10:30AM CST
- 21% Revenue Growth Fueled by Organic Growth and Acquisitions
STE: 62.66 (+0.22)

35.7% Return Seen to Date on SmarTrend STERIS Call (STE)
Comtex SmarTrend(R) - Fri Oct 31, 4:36PM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 9 months, STERIS has returned 35.69% as of today's recent price of $61.80.
STE: 62.66 (+0.22)

DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 29.42 (-0.11), STE: 62.66 (+0.22), HSIC: 122.21 (+1.37), XRAY: 51.62 (+0.85)

STERIS Corporation to Announce Fiscal 2015 Second Quarter Financial Results on November 5, 2014
Thomson Reuters ONE - Tue Oct 28, 8:49AM CDT
Mentor, Ohio (October 28, 2014) - STERIS Corporation (NYSE: STE) today announced that it will release its fiscal 2015 second quarter financial results before the market opens on November 5, 2014, followed by a conference call at 10:00 a.m. Eastern Standard Time. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 800-369-8428 in the United States and Canada, or 1-773-799-3378 internationally, then referencing the password "STERIS".
STE: 62.66 (+0.22)

CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 62.66 (+0.22), CNMD: 41.67 (-0.40), COO: 164.30 (+1.23)

STERIS Shares Up 31.5% Since SmarTrend's Buy Recommendation (STE)
Comtex SmarTrend(R) - Fri Oct 24, 10:57AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 8 months, STERIS has returned 31.53% as of today's recent price of $59.90.
STE: 62.66 (+0.22)

NYSE stocks posting largest percentage increases
AP - Thu Oct 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
CRS: 50.38 (+0.65), UFS: 40.32 (-0.71), CLV: 10.61 (+0.08), BBW: 18.32 (+0.53), CLF: 11.15 (-0.18), MTRN: 39.07 (+0.34), XRS: 31.78 (-0.25), GPI: 85.01 (+1.07), STE: 62.66 (+0.22), BRP: 23.24 (+0.02), TYL: 108.84 (-0.46), FUN: 47.83 (+0.09), UIS: 26.27 (+0.33), SIX: 39.94 (-0.11), TLLP: 56.03 (-0.03)

After Yesterday's Rally of 4.02% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:01PM CDT
STERIS (NYSE:STE) traded in a range yesterday that spanned from a low of $56.97 to a high of $59.21. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $56.87 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
STE: 62.66 (+0.22)

Upgrade Alert for STERIS (STE)
Comtex SmarTrend(R) - Wed Oct 22, 6:55AM CDT
STERIS (NYSE:STE) was upgraded from Market Perform to Strong Buy at Raymond James today. The stock closed yesterday at $56.68 on volume of 484,000 shares, below average daily volume of 545,000. STERIS (NYSE:STE) has potential upside of 9.1% based on a current price of $56.68 and analysts' consensus price target of $61.83. The stock should find initial support at its 50-day moving average (MA) of $55.58 and further support at its 200-day MA of $51.36.
STE: 62.66 (+0.22)

Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 62.66 (+0.22), CAH: 78.91 (-0.60), XRAY: 51.62 (+0.85), COO: 164.30 (+1.23)

Why STERIS (STE) Stock Is Gaining in Pre-Market Trading Today
at The Street - Mon Oct 13, 8:03AM CDT
STERIS (STE) stock is rising in pre-market trading after announcing it will purchase the U.K's Synergy Health for $1.9 billion in cash and stock.
STE: 62.66 (+0.22)

Steris to spend $1.9B on UK's Synergy Health
By TOM MURPHY - AP - Mon Oct 13, 7:03AM CDT
Steris Corp. will spend about $1.9 billion to buy a British sterilization services company, as U.S. businesses continue to seek overseas incorporations despite attempts to make such tax-saving maneuvers less lucrative.
MDT: 68.70 (+0.77), STE: 62.66 (+0.22), COV: 93.32 (+1.29)

European Stocks, Asian Shares Trade Mixed in Bumpy Trading
at The Street - Mon Oct 13, 5:46AM CDT
International markets are mixed early Monday.
STE: 62.66 (+0.22), LUX: 50.68 (+0.90), STO: 22.18 (+0.71)

STERIS to Acquire Synergy Health for $1.9 Billion in Cash and Stock
Thomson Reuters ONE - Mon Oct 13, 3:02AM CDT
Combination Creates a Global Leader in Infection Prevention and Sterilization
STE: 62.66 (+0.22)

STERIS Has Returned 27.4% Since SmarTrend Recommendation (STE)
Comtex SmarTrend(R) - Fri Oct 10, 9:54AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.54. In approximately 8 months, STERIS has returned 27.39% as of today's recent price of $58.02.
STE: 62.66 (+0.22)

Shares of STE Up 19.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Oct 03, 9:21AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 8 months, STERIS has returned 19.22% as of today's recent price of $54.30.
STE: 62.66 (+0.22)

Steris Corp. (STE) Stock Research Links

STE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Supply Crunch from CATL's Decision Triggers Lithium Market Rally

Updated Category News Views 98

CATL's Halt of Lithium Production Shakes Up the Market Recently, CATL grabbed attention by stopping operations at a significant lithium production site. This move, officially confirmed by the company, was a response to shifting conditions in the lithium carbonate market, particularly in Yichun. Effects on Lithium Supply and Pricing As a result of this suspension, China's...

Continue Reading
Cohen & Steers Fund Distribution Insights and Performance Update

Updated Category News Views 216

Understanding Distribution Sources for Cohen & Steers Fund Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) has provided vital information regarding the sources of its distributions. The fund aims to keep its shareholders well-informed about the dividends expected in the upcoming payment period. The Managed Distribution Policy Explained The fund's investment...

Continue Reading
SiteOne Landscape Supply: Insider Sell Raises Questions

Updated Category News Views 171

February 17 was a noteworthy date for SiteOne Landscape Supply (NYSE:SITE) as insider Eric Elema, the company's EVP, made waves with a substantial stock sale of 1,765 shares amounting to $278,887. Insider selling can often send mixed signals to the market; while it might raise eyebrows about internal confidence, it doesn’t always equate to a bearish sentiment on the...

Continue Reading
ArcBest Outlines Growth Strategies and Financial Goals for 2028

Updated Category News Views 244

ArcBest's Vision for Future Growth ArcBest is committed to a future of logistics excellence, emphasizing a strategy built on growth, efficiency, and innovation. At the recent investor day, the leadership team provided a roadmap for the company's journey towards ambitious financial targets set for 2028. Integrating Technology for Superior Logistics Solutions As a leading...

Continue Reading
Barolo and Barbaresco Academy Roadshow: A Wine Journey

Updated Category News Views 131

Barolo and Barbaresco Academy Roadshow Celebrates Success The Academy Roadshow recently concluded with a series of sold-out seminars across multiple cities in the Southwest, showcasing an increasing interest in Barolo and Barbaresco wines. This event gathered wine professionals and enthusiasts eager to deepen their understanding of these exceptional wines. Highlights of...

Continue Reading